"The Changing TAVR Landscape" is a comprehensive multiepisodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.
The Changing TAVR Landscape
8
episodes
1.00 program credits 53m
Details
Presenters
Comments
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Hemal Gada, MD
President, Heart and Vascular Institute
Co-Director, Structural Heart Program
UPMC Central PA
Harrisburg, PAResearch: Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Inc.
Consulting Fees: Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Inc.Renuka Jain, MD
Director of Echocardiography
Aurora St. Luke’s
Milwaukee, WIResearch: GE HealthCare
Consulting Fees: Medtronic Inc.Pam Taub, MD, FACC, FASPC
Cardiologist and Professor of Medicine
UC San Diego
La Jolla, CAConsulting Fees: Amarin, Amgen, Bayer, Boehringer Ingelheim, Esperion, Medtronic, Novartis, Novo Nordisk, Sanofi
Ownership Interest: Epirium BioSteven Yakubov, MD, MSCAI, FACC
System Chief
Structural Heart Disease
Riverside Methodist Hospital, Ohio Health
Columbus, OHResearch: Boston Scientific, Medtronic, Inc.
Consulting Fees: Boston Scientific, Medtronic, Inc.Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI
Professor of Medicine (Cardiology)
and Population Health Science and Policy
Director, Women’s Heart and Vascular Center
Mount Sinai Fuster Heart Hospital
Icahn School of Medicine at Mount Sinai
New York, NYResearch: Abbott, Abiomed, Affluent Medical, Alleviant Medical, Amgen, AM-Pharma, Arena, AstraZeneca, AtriCure Inc., Biosensors, Biotronik, Boston Scientific, Bristol Myers Squibb, CardiaWave, CeloNova, CERC, Chiesi, Cleerly Health Inc., Concept Medical, Cytosorbents, Daiichi Sankyo, Duke, Element Science, Essential Medical, Faraday, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere, Medtelligence, Medtronic, MJH Healthcare, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Population Health Research Institute, Protembis, RecCor Medical Inc., RenalPro, RM Global, Sanofi, Shockwave, Vivasure, Zoll
Ownership Interest: Equity <1% in: Elixir Medical, Stel, CntrolRad (spouse)
Consulting Fees: Affluent Medical, Boehringer Ingelheim, Cardiovascular Research Foundation (CRF), Cordis, Daiichi Sankyo Brasil, E.R. Squibb & Sons, Esperion Science/Innovative Biopharma, Europa Group/Boston Scientific, Gaffney Events, Educational Trust, Henry Ford Health Cardiology, Ionis Pharmaceuticals, Lilly and Company, MedCon International, Novartis, NovoNordisk, PeerView Institute for Medical Education, TERUMO Europe N.V., Vectura, VoxMedia, WebMD, IQVIA, Radcliffe, TARSUS Cardiology
Honorarium: JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program)Ashish Aneja, MD
Associate Professor of Medicine
Case Western Reserve University
MetroHeath Campus
Cleveland, OHConsulting Fees: Bristol Myers Squibb, Medtronic
Deepak Talreja, MD, FACC
Clinic Chief of Cardiology, Sentara Health
Assistant Professor, Eastern Virginia Medical School
Norfolk, VASpeakers Bureaus: Bristol Myers Squibb, Camzyos, AstraZeneca, Farxiga, Bayer, Boehringer-Inlgeheim/Lilly, Kiniksa, Arcalyst, Medicure, Zoll, Novo Nordisk, Acarix
Proctor: Medtronic, Edwards, Life Sciences, Abbott, PortocoElana Koss, MD
Director
North Shore University Hospital
Manhasset, NYResearch: Edwards Lifescience, Medtronic, Abbott
Consulting Fees: Edward Life Science, Medtronic, AbbottAnene Ukaigwe, MD
Interventional and Structural Cardiologist
University Hospital, Harrington Heart and Vascular Institute
Cleveland, OHConsulting Fees: Medtronic, Inc.
Reviewers/Content Planners/Authors:
- Cindy Davidson has nothing to disclose.
- Howard Green has nothing to disclose.
- Samantha Keehn has nothing to disclose.
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
- Tim Person has nothing to disclose.
- Colleen Resnick has nothing to disclose.
- Mario Trucillo, PhD, MS has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Recognize the symptoms and biomarkers of aortic stenosis to help improve diagnosis
- Review the clinical trial data on the safety and efficacy of transcatheter aortic valve replacement (TAVR)
- Select appropriate patients for referral to specialist care
- Effectively employ the use of echocardiography in the diagnosis of patients with aortic stenosis
Target Audience
This activity is designed to meet the educational needs of General Cardiologists, Primary Care Professionals, Nurses, and PA’s.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Global Learning Collaborative (GLC) designates this activity for 1.00 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 1/24/2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.Provider(s)/Educational Partner(s)
Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
Commercial Support
This activity is supported by an independent educational grant from Medtronic.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
